Evaluation of Mirtazapine and Folic Acid for Schizophrenia:

NCT01263080 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

333

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: mirtazapine
DRUG: folic acid placebo
DRUG: mirtazapine placebo
DRUG: folic acid

Sponsor

Capital Medical University